Stationary Cycling Exercise With Virtual Reality to Reduce Depressive Symptoms Among People With Mild to Moderate Depression: Randomized Controlled Trial

Na Zhang, Chenlu Hong, Yuejia Wang, Haiqin Chen, Yaping Zhu, Da Miao, Zhongxia Shen, Xudong Zhao, Jiali Xu, Jifang Sheng, Yanan Luo, Xu MeiyingJournal of Medical Internet Research 2025 · DOI

TL;DR

This study demonstrates that virtual reality (VR) enhanced stationary cycling is an effective intervention for reducing depressive symptoms in individuals with mild to moderate depression. The VR approach led to significantly greater improvements in depressive symptoms and higher patient satisfaction compared to traditional stationary cycling, suggesting its potential as a valuable complementary treatment.

What Problem Does This Paper Address?

Depression is a widespread mental health issue with significant impacts on individuals and society. While exercise is recognized as a beneficial non-pharmacological treatment, adherence can be a major challenge. Virtual reality (VR) offers a promising avenue to enhance engagement and motivation in exercise interventions. However, high-quality evidence supporting the efficacy of VR-based exercise, particularly in the context of stationary cycling for depression, has been lacking. This paper aims to fill that gap by evaluating the clinical effects of a 12-week VR-based stationary cycling program on depressive symptoms in sedentary adults with mild to moderate depression.

Methods

This was a 12-week, 3-arm randomized controlled double-blind trial. Participants diagnosed with mild to moderate depression were recruited and randomly assigned to one of three groups:

  • VR High-Intensity Stationary Cycling: Participants engaged in VR cycling with intermittent high-intensity intervals.
  • VR Moderate-Intensity Stationary Cycling: Participants engaged in VR cycling with moderate-intensity intervals.
  • Non-VR Moderate-Intensity Stationary Cycling: Participants engaged in traditional stationary cycling without VR.

The primary outcome measured was the change in depressive symptoms using the Hamilton Depression Rating Scale (HAMD-17) from baseline to 12 weeks. Secondary outcomes included response rate, remission rate, patient satisfaction, and exercise adherence. The study employed an intention-to-treat (ITT) approach for analysis.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • VR significantly boosts exercise engagement: The immersive nature of VR appears to be a key factor in improving adherence and satisfaction with stationary cycling, addressing a common barrier in depression treatment.
  • Multimodal approach is effective: Combining VR with stationary cycling offers a synergistic effect, enhancing the therapeutic benefits beyond traditional exercise alone.
  • Moderate intensity might be preferred: While both VR intensities showed significant improvements, the moderate-intensity VR group reported higher satisfaction, suggesting a potential sweet spot for patient experience.
  • VR as a viable clinical tool: The findings support the integration of VR-based interventions into clinical practice for depression management, offering a novel and engaging treatment option.

Key Results

  • Significant symptom reduction: All three groups showed significant improvements in depressive symptoms. However, both VR groups (moderate and high intensity) demonstrated significantly greater reductions in HAMD-17 scores compared to the non-VR group.
  • Response and remission rates: The VR groups achieved substantially higher response rates (84% for moderate, 92% for high intensity) and remission rates (74% for both VR groups) compared to the non-VR group (58% response, 39% remission).
  • No significant difference between VR intensities: While both VR groups were superior to the non-VR group, there was no statistically significant difference in symptom improvement between the VR moderate-intensity and VR high-intensity cycling groups.
  • Higher satisfaction with VR: Patient satisfaction was significantly higher in the VR moderate-intensity group compared to both the VR high-intensity and non-VR groups.
  • Improved adherence: Compliance levels were significantly higher in the VR moderate-intensity group compared to the non-VR group.
  • Safety: No adverse events were reported across any of the groups.

Limitations and Future Work

The authors acknowledge several limitations:

  • Practice effect: It's challenging to completely disentangle the effects of VR from potential practice effects of repeated exercise.
  • Single-region study: The study was conducted in China, which may limit the generalizability of findings to other cultural contexts.
  • Lack of non-exercise control group: The absence of a group that did not engage in any exercise makes it difficult to determine the absolute treatment effect compared to standard care.
  • VR customization: Future research could explore how personalized VR experiences might further enhance adherence and outcomes.
  • Long-term effects: The study did not assess long-term adherence or the sustainability of VR cycling's effectiveness post-intervention.

Future work should focus on multicenter trials, cost-effectiveness analyses, and investigating the impact of VR customization and long-term follow-up to optimize its clinical application.

Summary updated

Abstract

The VR stationary cycling program is an efficacious health intervention for alleviating depressive symptoms in participants with mild to moderate depression. These findings could facilitate incorporating VR health intervention into clinical practice, enhance the response of cycling-based interventions, and improve patient adherence, supporting its use as a complementary treatment for depression.
BibTeX
@article{zhang2025stationary,
  author = {Na Zhang and Chenlu Hong and Yuejia Wang and Haiqin Chen and Yaping Zhu and Da Miao and Zhongxia Shen and Xudong Zhao and Jiali Xu and Jifang Sheng and Yanan Luo and Xu Meiying},
  title = {{Stationary Cycling Exercise With Virtual Reality to Reduce Depressive Symptoms Among People With Mild to Moderate Depression: Randomized Controlled Trial}},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  doi = {10.2196/72021},
}
Figure